Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Jens-Ulrich Stegmann"'
Autor:
Christophe Dessart, Fernanda Tavares-Da-Silva, Lionel Van Holle, Olivia Mahaux, Jens-Ulrich Stegmann
Publikováno v:
Advances in Pharmacological and Pharmaceutical Sciences, Vol 2024 (2024)
A European legislation was put in place for the reporting of medication errors, and guidelines were drafted to help stakeholders in the reporting, evaluation, and, ultimately, minimization of these errors. As part of pharmacovigilance reporting, a pr
Externí odkaz:
https://doaj.org/article/dd3d1bb4a4a8453695cc30c9673b4e79
Autor:
Jens-Ulrich Stegmann, Viviane Jusot, Olga Menang, Gregory Gardiner, Sabino Vesce, Stephanie Volpe, Anderson Ndalama, Felix Adou, Opokua Ofori-Anyinam, Olakunle Oladehin, Yolanda Guerra Mendoza
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Pharmacovigilance (PV) systems in many countries in sub-Saharan Africa (SSA) are not fully functional. The spontaneous adverse events (AE) reporting rate in SSA is lower than in any other region of the world, and healthcare professionals (HC
Externí odkaz:
https://doaj.org/article/2acea930bccf46ebbab25be96f968631
Autor:
Yolanda Guerra Mendoza, Elodie Garric, Amanda Leach, Marc Lievens, Opokua Ofori-Anyinam, Jean-Yves Pirçon, Jens-Ulrich Stegmann, Pascale Vandoolaeghe, Lucas Otieno, Walter Otieno, Seth Owusu-Agyei, Jahit Sacarlal, Nahya Salim Masoud, Hermann Sorgho, Marcel Tanner, Halidou Tinto, Innocent Valea, Ali Takadir Mtoro, Patricia Njuguna, Martina Oneko, Godfrey Allan Otieno, Kephas Otieno, Samwel Gesase, Mary J Hamel, Irving Hoffman, Seyram Kaali, Portia Kamthunzi, Peter Kremsner, Miguel Lanaspa, Bertrand Lell, John Lusingu, Anangisye Malabeja, Pedro Aide, Pauline Akoo, Daniel Ansong, Kwaku Poku Asante, James A Berkley, Samuel Adjei, Tsiri Agbenyega, Selidji Todagbe Agnandji, Lode Schuerman
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 10, Pp 2386-2398 (2019)
A phase III, double-blind, randomized, controlled trial (NCT00866619) in sub-Saharan Africa showed RTS,S/AS01 vaccine efficacy against malaria. We now present in-depth safety results from this study. 8922 children (enrolled at 5–17 months) and 6537
Externí odkaz:
https://doaj.org/article/32543b5d892e42548e7e71deabcf0cf8
Autor:
Frank Huygen, Kristin Verschueren, Candida McCabe, Jens-Ulrich Stegmann, Julia Zima, Olivia Mahaux, Lionel Van Holle, Maria-Genalin Angelo
Publikováno v:
EBioMedicine, Vol 2, Iss 9, Pp 1114-1121 (2015)
Complex regional pain syndrome (CRPS) is a chronic pain disorder that typically follows trauma or surgery. Suspected CRPS reported after vaccination with human papillomavirus (HPV) vaccines led to temporary suspension of proactive recommendation of H
Externí odkaz:
https://doaj.org/article/5fbfeda6fcbe4c86a82a399e4bcd4760
Publikováno v:
Journal of Pain Research, Vol 2010, Iss default, Pp 1-9 (2010)
Marc Afilalo1, Jens-Ulrich Stegmann2, David Upmalis31Sir Mortimer B. Davis Jewish General Hospital, Montréal, Canada; 2Global Drug Safety, Grünenthal GmbH, Aachen, Germany; 3Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Raritan
Externí odkaz:
https://doaj.org/article/140ad4a4c5094dbd97d5a23d50721591
Autor:
Jens-Ulrich Stegmann, Fernanda Tavares-Da-Silva, Paola Pirrotta, Nicolas Lecrenier, Caroline Hervé, Maribel Miranda Co
Publikováno v:
Drug Safety
Introduction With the approval of the adjuvanted recombinant zoster vaccine (RZV; Shingrix, GSK) in October 2017, GSK established enhanced safety surveillance measures to allow prompt identification of potential safety signals not observed during cli
Autor:
Andrew Bate, Jens-Ulrich Stegmann
Publikováno v:
Health Policy and Technology. :100743
Autor:
Olakunle Oladehin, Frider Chimimba, Gregory Gardiner, Nettie Dzabala, Opokua Ofori-Anyinam, Mphatso Kawaye, Olga Menang, Cecilia Sambakunsi, Jens-Ulrich Stegmann, Viviane Jusot, Yolanda Guerra Mendoza, Joy Cole
Publikováno v:
Drug Safety
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV. Objective The objective of this initiati
Autor:
Andrew Bate, Jens-Ulrich Stegmann
Publikováno v:
Trends in pharmacological sciences. 42(12)
The systematic safety surveillance of real-world use of medicinal products and related activities (pharmacovigilance) started in earnest as a scientific field only in the 1960s. While developments have occurred over the past 50 years, adding to its c
Autor:
Nettie Dzabala, Joy Cole, Olakunle Oladehin, Frider Chimimba, Mphatso Kawaye, Opokua Ofori-Anyinam, Olga Menang, Jens-Ulrich Stegmann, Gregory Gardiner, Cecilia Sambakunsi, Viviane Jusot, Yolanda Guerra Mendoza
Publikováno v:
Drug Saf
Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.The objective of this initiative was to improve report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12cec9fb50b0b83837c4cf92fbb455be
https://europepmc.org/articles/PMC8496567/
https://europepmc.org/articles/PMC8496567/